Literature DB >> 23419617

Psychometric properties of the Quick Inventory of Depressive Symptomatology (QIDS-SR) in UK primary care.

Isobel M Cameron1, John R Crawford, Amanda H Cardy, Schalk W du Toit, Kenneth Lawton, Steven Hay, Kenneth Mitchell, Sumit Sharma, Shilpa Shivaprasad, Sally Winning, Ian C Reid.   

Abstract

It is widely believed that severity of depressive disorder should guide treatment selection and many guidelines emphasise this factor. The Quick Inventory of Depressive Symptomatology (QID-SR16) is a self-complete measure of depression severity which includes all DSM-IV criterion symptoms for major depressive disorder. The object of this study was to assess the psychometric properties of the QIDS-SR16 in a primary care sample. Adult primary care patients completed the QIDS-SR16 and were assessed by a psychiatrist (blind to QIDS-SR16) with the 17-item Hamilton Rating Scale for Depression (GRID-HAMD). Internal consistency, homogeneity and convergent and discriminant validity of the QIDS-SR16 were assessed. Severity cut-off scores for QIDS-SR16 were assessed for convergence with HRSD-17 cut-offs. Published methods for converting scores to HRSD-17 were also assessed. Two hundred and eighty-six patients participated: mean age = 49.5 (s.d. = 13.8), 68% female, mean HRSD-17 = 12.6 (s.d. = 7.6). The QIDS-SR16 exhibited acceptable internal consistency (Cronbach's alpha = 0.86), a robust factor structure indicating one underlying dimension and correlated highly with the HRSD-17 (r = 0.79) but differed significantly in how it categorised the severity of depression relative to the HRSD-17 (Wilcoxon Signed Rank Test p < 0.001). Using published methods to convert QIDS-SR16 scores to HRSD-17 scores did not result in alignment of severity categorisation. In conclusion, psychometric properties of the QIDS-SR16 were found to be strong in terms of internal consistency, factor structure and convergent and discriminant validity. Using conventional scoring and conversion methods the scale was found not to concur with the HRSD-17 in categorising the severity of depressive symptoms.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23419617     DOI: 10.1016/j.jpsychires.2013.01.019

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  6 in total

1.  A Preliminary Examination of the Effect of Cognitive Processing Therapy on Sleep Disturbance Among Veterans with Military Sexual Trauma-Related Posttraumatic Stress Disorder.

Authors:  Nicholas Holder; Ryan Holliday; Jessica Wiblin; Alina Surís
Journal:  Traumatology (Tallahass Fla)       Date:  2019-04-11

2.  Lasting impression of violence: Retained bullets and depressive symptoms.

Authors:  Randi N Smith; Mark J Seamon; Vinayak Kumar; Andrew Robinson; Justine Shults; Patrick M Reilly; Therese S Richmond
Journal:  Injury       Date:  2017-09-04       Impact factor: 2.586

3.  Clinical Insight Into Latent Variables of Psychiatric Questionnaires for Mood Symptom Self-Assessment.

Authors:  Athanasios Tsanas; Kate Saunders; Amy Bilderbeck; Niclas Palmius; Guy Goodwin; Maarten De Vos
Journal:  JMIR Ment Health       Date:  2017-05-25

4.  Characterization of suicidal depression: a one-year prospective study.

Authors:  B Nobile; E Olié; J Dubois; M Benramdane; S Guillaume; Ph Courtet
Journal:  Eur Psychiatry       Date:  2022-04-18       Impact factor: 7.156

5.  Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report.

Authors:  Taylor A Braund; Gabriel Tillman; Donna M Palmer; Evian Gordon; A John Rush; Anthony W F Harris
Journal:  Transl Psychiatry       Date:  2021-08-04       Impact factor: 6.222

6.  Validation of the Malay Self-Report Quick Inventory of Depressive Symptomatology in a Malaysian Sample.

Authors:  Lai Fong Chan; Choon Leng Eu; Seng Fah Tong; Song Jie Chin; Shalisah Sharip; Yee Chin Chai; Jiann Lin Loo; Nurul Ain Mohamad Kamal; Jo Aan Goon; Raynuha Mahadevan; Chian Yong Liu; Chih Nie Yeoh; Tuti Iryani Mohd Daud
Journal:  Int J Environ Res Public Health       Date:  2022-02-28       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.